plantar fasciitis
Conditions
Interventions
Control group Sample size:Placebo without any preservatives and toxin, 1 bottle
Sponsors
The Application hospital of Qingdao university
Eligibility
Sex/Gender
All
Age
17 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. skeletal maturity, heel pain plantar fascia is inserted at the front or at the tuberosity of the calcaneus; 2. failure of conservative treatment for 3 months, including ordinary insole and nonsteroidal anti-inflammatory drug; 3. and visual analog Table (VAS) is more than 40 mm in pain intensity; 4. plantar fascia rupture or plantar fascia more than 4 mm, and echo reduction.
Exclusion criteria
Exclusion criteria: 1. an open wound of the foot or heel, history of foot surgery or fracture; 2. Related diseases: knee or ankle dysfunction, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, Reiters syndrome; 3. Injection of plantar fasciitis in the first six months; 4. lumbal vertebra; 5. Lidocaine allergy history; 6. prior treatment with BoNT-A, existing diagnosed allergies or antibodies against BoNT-A; 7. history of chronic narcotic use for any reason; 8. a history of infection in the previous 3 months, at the application site.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS;FADI;AOFAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| plantar fascia thickness;elasticity;Foot Infrared Thermal Imaging;SF-36; | — |
Countries
China
Contacts
Public ContactTieshan Li
Qingdao University
Outcome results
None listed